Literature DB >> 29450351

Glaucoma after chemical burns and radiation.

Cornel Ştefan1, Cristina Mihaela Timaru1, Daniela Adriana Iliescu1, Speranta Schmitzer2,3, Simone De Algerino1, Mehdi Batras1, Jalaladin Hosseini-Ramhormozi1.   

Abstract

Glaucoma after chemical burns represents a posttraumatic glaucoma, usually open-angle glaucoma. It is a frequent complication of chemical burns, especially with alkali and it can appear in the acute stage or as a late complication. Because of the complications and scars, the treatment is very difficult. Topical treatment is based on AC inhibitors, β-blockers, α2-agonists. Trabeculectomy, shunts, cyclophotocoagulation, and cryotherapy are the solutions in the late stages. Glaucoma after irradiation is a closing-angle secondary glaucoma. The risk factors such as the radiation dose and the volume of the radiated structure are important in the appearance and evolution of this type of glaucoma. Topical treatment is usually ineffective, the preferable options being laser and surgical treatments. Although it is not a frequently seen pathology, it is important to know how to diagnose and treat this type of glaucoma. There are various options available for treatment, but choosing one is difficult because of the possible complications.

Entities:  

Keywords:  IOP; alkali; chemical burn; radiation; secondary glaucoma

Mesh:

Substances:

Year:  2016        PMID: 29450351      PMCID: PMC5711283     

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  7 in total

Review 1.  Management of ocular thermal and chemical injuries, including amniotic membrane therapy.

Authors:  Robert Fish; Richard S Davidson
Journal:  Curr Opin Ophthalmol       Date:  2010-07       Impact factor: 3.761

2.  Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.

Authors:  Fabiano Cade; Cynthia L Grosskreutz; Allyson Tauber; Claes H Dohlman
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

3.  Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.

Authors:  Naoki Hirasawa; Hiroshi Tsuji; Hitoshi Ishikawa; Hiroko Koyama-Ito; Tadashi Kamada; Jun-Etsu Mizoe; Yoshiyuki Ito; Shinji Naganawa; Yoshitaka Ohnishi; Hirohiko Tsujii
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-04       Impact factor: 7.038

4.  Incidence and prevalence of glaucoma in severe ocular surface disease.

Authors:  Julie H Tsai; Elizabeth Derby; Edward J Holland; Anup K Khatana
Journal:  Cornea       Date:  2006-06       Impact factor: 2.651

5.  [Glaucoma after extremely severe chemical and thermal eye burns. Surgical possibilities].

Authors:  R Kuckelkorn; G K Keller; C Redbrake
Journal:  Ophthalmologe       Date:  2001-12       Impact factor: 1.059

6.  Glaucoma in patients with ocular chemical burns.

Authors:  Michelle P Lin; Ümit Ekşioğlu; Raghu C Mudumbai; Mark A Slabaugh; Philip P Chen
Journal:  Am J Ophthalmol       Date:  2012-05-24       Impact factor: 5.258

7.  Radiation-induced neovascular glaucoma: dose and volume issues.

Authors:  Ah Ram Chang
Journal:  Korean J Ophthalmol       Date:  2010-11-23
  7 in total
  3 in total

1.  Th17 Activation and Th17/Treg Imbalance in Prolonged Anterior Intraocular Inflammation after Ocular Alkali Burn.

Authors:  Miner Yuan; Xiaobing Qian; Yanqiao Huang; Xinqi Ma; Fang Duan; Yao Yang; Bingsheng Lou; Xiaofeng Lin
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

2.  Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair.

Authors:  Alejandro Navas; Fátima Sofía Magaña-Guerrero; Alfredo Domínguez-López; César Chávez-García; Graciela Partido; Enrique O Graue-Hernández; Francisco Javier Sánchez-García; Yonathan Garfias
Journal:  Stem Cells Transl Med       Date:  2018-09-10       Impact factor: 6.940

3.  Effect of Tauroursodeoxycholic Acid on Inflammation after Ocular Alkali Burn.

Authors:  Yanqiao Huang; Lixia Lin; Yao Yang; Fang Duan; Miner Yuan; Bingsheng Lou; Xiaofeng Lin
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.